Detalhe da pesquisa
1.
Impact of TAILORx on chemotherapy prescribing and 21-gene recurrence score-guided treatment costs in a population-based cohort of patients with breast cancer.
Cancer
; 128(4): 665-674, 2022 Feb 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-34855202
2.
Impact of new cancer therapies on outpatient treatment delivery for colorectal cancer: A population-based study.
Int J Health Plann Manage
; 37(1): 258-270, 2022 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-34545610
3.
The impact of new systemic therapies on survival and time on hormonal treatment in hormone receptor-positive, human epidermal growth factor receptor 2-negative metastatic breast cancer: A population-based study in British Columbia from 2003 to 2013.
Cancer
; 126(5): 971-977, 2020 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31750938
4.
Outcomes of Surgical and Chemotherapeutic Treatments of Goblet Cell Carcinoid Tumors of the Appendix.
Ann Surg Oncol
; 25(8): 2391-2399, 2018 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-29916007
5.
Prognostic Factors for Locoregional Recurrence in Neuroendocrine Tumors of the Rectum.
Dis Colon Rectum
; 61(2): 187-192, 2018 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-29337773
6.
The utility of abbreviated patient-reported outcomes for predicting survival in early stage colorectal cancer.
Cancer
; 123(10): 1839-1847, 2017 05 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-28081292
7.
Survival with metastatic breast cancer based on initial presentation, de novo versus relapsed.
Breast Cancer Res Treat
; 161(3): 549-556, 2017 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-28000014
8.
Adjuvant chemotherapy use and outcomes of patients with high-risk versus low-risk stage II colon cancer.
Cancer
; 121(4): 527-34, 2015 Feb 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-25332117
9.
Effect of M1a and M1b category in metastatic colorectal cancer.
Oncologist
; 19(7): 720-6, 2014 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-24899642
10.
Does age affect outcome with breast cancer?
Breast
; 70: 25-31, 2023 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-37300985
11.
Treatment Patterns and Outcomes of Preoperative Neoadjuvant Radiotherapy in Patients with Early-onset Rectal Cancer.
Cancer Res Commun
; 3(4): 548-557, 2023 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-37035581
12.
Molecular alterations between the primary breast cancer and the subsequent locoregional/metastatic tumor.
Oncologist
; 17(2): 172-8, 2012.
Artigo
em Inglês
| MEDLINE | ID: mdl-22267852
13.
Assessing the real-world cost-effectiveness of adjuvant trastuzumab in HER-2/neu positive breast cancer.
Oncologist
; 17(2): 164-71, 2012.
Artigo
em Inglês
| MEDLINE | ID: mdl-22302231
14.
Response to "Do metastasis-free interval less or more than 24 months for recurrent metastatic breast cancer and primary surgery for de novo metastatic breast cancer matter for survival?"
Breast Cancer Res Treat
; 162(2): 397-398, 2017 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-28110478
15.
Effect of community population size on breast cancer screening, stage distribution, treatment use and outcomes.
Can J Public Health
; 103(1): 46-52, 2012.
Artigo
em Inglês
| MEDLINE | ID: mdl-22338328
16.
Locoregional Recurrence and Survival Outcomes in Breast Cancer Treated With Modern Neoadjuvant Chemotherapy: A Contemporary Population-based Analysis.
Clin Breast Cancer
; 22(7): e773-e787, 2022 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-35915021
17.
pN0(i+) and pN1mi Breast Cancer: Treatment and Outcomes in Comparison With pN0 and pN1a in the Modern Era.
Int J Radiat Oncol Biol Phys
; 113(4): 805-815, 2022 07 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-35385784
18.
Association Between Regional Nodal Irradiation and Breast Cancer Recurrence-Free Interval for Patients With Low-Risk, Node-Positive Breast Cancer.
Int J Radiat Oncol Biol Phys
; 112(4): 861-869, 2022 03 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-34762971
19.
Breast Tangent Beam Energy, Surgical Bed-to-Skin Distance and Local Recurrence After Breast-Conserving Treatment.
Int J Radiat Oncol Biol Phys
; 112(3): 671-680, 2022 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34699929
20.
Characterizing the KRAS G12C mutation in metastatic colorectal cancer: a population-based cohort and assessment of expression differences in The Cancer Genome Atlas.
Ther Adv Med Oncol
; 14: 17588359221097940, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35694189